Biotech Values

[DewDiligence]

>> Somewhat concerned that the Foundation Fighting Blindness website does not include any information on GENR's recent clinical trials with Squalamine. I see many others mentioned, including one for Combretastatin that is currently recruiting. Any logical reason for GENR's absence? >>

The Combretastatin trial is cited by FFB’s website because it is currently enrolling patients. Closed clinical trials conducted in the U.S. may also be listed for reference purposes.

When GENR has an AMD trial in the U.S.undergoing patient recruitment, FFB will list GENR’s trial too.

P.S. Dr. Chader, the president of FFB, spoke at GENR's Aug 4 CC.